Global Biologics and Biosimilars Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Biologics and Biosimilars Product Introduction
1.2 Market Segments
1.3 Key Biologics and Biosimilars Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biologics and Biosimilars Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Interferon
1.4.4 Erythropoietin
1.4.5 Insulin
1.4.6 Vaccines
1.4.7 Other
1.5 Market by Application
1.5.1 Global Biologics and Biosimilars Market Size Growth Rate by Application
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Biologics and Biosimilars Industry Impact
1.6.1 How the Covid-19 is Affecting the Biologics and Biosimilars Industry
1.6.1.1 Biologics and Biosimilars Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biologics and Biosimilars Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biologics and Biosimilars Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Biologics and Biosimilars Market Size Estimates and Forecasts
2.1.1 Global Biologics and Biosimilars Revenue 2015-2026
2.1.2 Global Biologics and Biosimilars Sales 2015-2026
2.2 Biologics and Biosimilars Market Size by Region: 2020 Versus 2026
2.2.1 Global Biologics and Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biologics and Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biologics and Biosimilars Competitor Landscape by Players
3.1 Biologics and Biosimilars Sales by Manufacturers
3.1.1 Biologics and Biosimilars Sales by Manufacturers (2015-2020)
3.1.2 Biologics and Biosimilars Sales Market Share by Manufacturers (2015-2020)
3.2 Biologics and Biosimilars Revenue by Manufacturers
3.2.1 Biologics and Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 Biologics and Biosimilars Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biologics and Biosimilars Revenue in 2019
3.2.5 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biologics and Biosimilars Price by Manufacturers
3.4 Biologics and Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biologics and Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologics and Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Biologics and Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Biologics and Biosimilars Market Size by Type (2015-2020)
4.1.1 Global Biologics and Biosimilars Sales by Type (2015-2020)
4.1.2 Global Biologics and Biosimilars Revenue by Type (2015-2020)
4.1.3 Biologics and Biosimilars Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biologics and Biosimilars Market Size Forecast by Type (2021-2026)
4.2.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global Biologics and Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 Biologics and Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biologics and Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Biologics and Biosimilars Market Size by Application (2015-2020)
5.1.1 Global Biologics and Biosimilars Sales by Application (2015-2020)
5.1.2 Global Biologics and Biosimilars Revenue by Application (2015-2020)
5.1.3 Biologics and Biosimilars Price by Application (2015-2020)
5.2 Biologics and Biosimilars Market Size Forecast by Application (2021-2026)
5.2.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global Biologics and Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global Biologics and Biosimilars Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biologics and Biosimilars by Country
6.1.1 North America Biologics and Biosimilars Sales by Country
6.1.2 North America Biologics and Biosimilars Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biologics and Biosimilars Market Facts & Figures by Type
6.3 North America Biologics and Biosimilars Market Facts & Figures by Application
7 Europe
7.1 Europe Biologics and Biosimilars by Country
7.1.1 Europe Biologics and Biosimilars Sales by Country
7.1.2 Europe Biologics and Biosimilars Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologics and Biosimilars Market Facts & Figures by Type
7.3 Europe Biologics and Biosimilars Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biologics and Biosimilars by Region
8.1.1 Asia Pacific Biologics and Biosimilars Sales by Region
8.1.2 Asia Pacific Biologics and Biosimilars Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biologics and Biosimilars Market Facts & Figures by Type
8.3 Asia Pacific Biologics and Biosimilars Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biologics and Biosimilars by Country
9.1.1 Latin America Biologics and Biosimilars Sales by Country
9.1.2 Latin America Biologics and Biosimilars Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biologics and Biosimilars Market Facts & Figures by Type
9.3 Central & South America Biologics and Biosimilars Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biologics and Biosimilars by Country
10.1.1 Middle East and Africa Biologics and Biosimilars Sales by Country
10.1.2 Middle East and Africa Biologics and Biosimilars Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Biologics and Biosimilars Market Facts & Figures by Type
10.3 Middle East and Africa Biologics and Biosimilars Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Biologics and Biosimilars Products Offered
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Biologics and Biosimilars Products Offered
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Description, Business Overview and Total Revenue
11.3.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AbbVie Biologics and Biosimilars Products Offered
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Corporation Information
11.4.2 Sanofi-Aventis Description, Business Overview and Total Revenue
11.4.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi-Aventis Biologics and Biosimilars Products Offered
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Biologics and Biosimilars Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Biologics and Biosimilars Products Offered
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Corporation Information
11.7.2 Novo Nordisk Description, Business Overview and Total Revenue
11.7.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novo Nordisk Biologics and Biosimilars Products Offered
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Corporation Information
11.8.2 Eli Lilly Description, Business Overview and Total Revenue
11.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly Biologics and Biosimilars Products Offered
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Description, Business Overview and Total Revenue
11.9.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis Biologics and Biosimilars Products Offered
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Corporation Information
11.10.2 Merck Description, Business Overview and Total Revenue
11.10.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Merck Biologics and Biosimilars Products Offered
11.10.5 Merck Recent Development
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Biologics and Biosimilars Products Offered
11.1.5 Roche Recent Development
11.12 Changchun High Tech
11.12.1 Changchun High Tech Corporation Information
11.12.2 Changchun High Tech Description, Business Overview and Total Revenue
11.12.3 Changchun High Tech Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Changchun High Tech Products Offered
11.12.5 Changchun High Tech Recent Development
11.13 CP Guojian
11.13.1 CP Guojian Corporation Information
11.13.2 CP Guojian Description, Business Overview and Total Revenue
11.13.3 CP Guojian Sales, Revenue and Gross Margin (2015-2020)
11.13.4 CP Guojian Products Offered
11.13.5 CP Guojian Recent Development
11.14 Biotech
11.14.1 Biotech Corporation Information
11.14.2 Biotech Description, Business Overview and Total Revenue
11.14.3 Biotech Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Biotech Products Offered
11.14.5 Biotech Recent Development
11.15 Gelgen
11.15.1 Gelgen Corporation Information
11.15.2 Gelgen Description, Business Overview and Total Revenue
11.15.3 Gelgen Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Gelgen Products Offered
11.15.5 Gelgen Recent Development
11.16 Innovent
11.16.1 Innovent Corporation Information
11.16.2 Innovent Description, Business Overview and Total Revenue
11.16.3 Innovent Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Innovent Products Offered
11.16.5 Innovent Recent Development
11.17 Dong Bao
11.17.1 Dong Bao Corporation Information
11.17.2 Dong Bao Description, Business Overview and Total Revenue
11.17.3 Dong Bao Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Dong Bao Products Offered
11.17.5 Dong Bao Recent Development
11.18 Ganlee
11.18.1 Ganlee Corporation Information
11.18.2 Ganlee Description, Business Overview and Total Revenue
11.18.3 Ganlee Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Ganlee Products Offered
11.18.5 Ganlee Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biologics and Biosimilars Market Estimates and Projections by Region
12.1.1 Global Biologics and Biosimilars Sales Forecast by Regions 2021-2026
12.1.2 Global Biologics and Biosimilars Revenue Forecast by Regions 2021-2026
12.2 North America Biologics and Biosimilars Market Size Forecast (2021-2026)
12.2.1 North America: Biologics and Biosimilars Sales Forecast (2021-2026)
12.2.2 North America: Biologics and Biosimilars Revenue Forecast (2021-2026)
12.2.3 North America: Biologics and Biosimilars Market Size Forecast by Country (2021-2026)
12.3 Europe Biologics and Biosimilars Market Size Forecast (2021-2026)
12.3.1 Europe: Biologics and Biosimilars Sales Forecast (2021-2026)
12.3.2 Europe: Biologics and Biosimilars Revenue Forecast (2021-2026)
12.3.3 Europe: Biologics and Biosimilars Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biologics and Biosimilars Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biologics and Biosimilars Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biologics and Biosimilars Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biologics and Biosimilars Market Size Forecast by Region (2021-2026)
12.5 Latin America Biologics and Biosimilars Market Size Forecast (2021-2026)
12.5.1 Latin America: Biologics and Biosimilars Sales Forecast (2021-2026)
12.5.2 Latin America: Biologics and Biosimilars Revenue Forecast (2021-2026)
12.5.3 Latin America: Biologics and Biosimilars Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biologics and Biosimilars Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biologics and Biosimilars Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biologics and Biosimilars Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biologics and Biosimilars Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Biologics and Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologics and Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of TablesTable 1. Biologics and Biosimilars Market Segments
Table 2. Ranking of Global Top Biologics and Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biologics and Biosimilars Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Interferon
Table 6. Major Manufacturers of Erythropoietin
Table 7. Major Manufacturers of Insulin
Table 8. Major Manufacturers of Vaccines
Table 9. Major Manufacturers of Other
Table 10. COVID-19 Impact Global Market: (Four Biologics and Biosimilars Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Biologics and Biosimilars Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Biologics and Biosimilars Players to Combat Covid-19 Impact
Table 15. Global Biologics and Biosimilars Market Size Growth Rate by Application 2020-2026 (K Units)
Table 16. Global Biologics and Biosimilars Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 17. Global Biologics and Biosimilars Sales by Regions 2015-2020 (K Units)
Table 18. Global Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Table 19. Global Biologics and Biosimilars Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Biologics and Biosimilars Sales by Manufacturers (2015-2020) (K Units)
Table 21. Global Biologics and Biosimilars Sales Share by Manufacturers (2015-2020)
Table 22. Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics and Biosimilars as of 2019)
Table 24. Biologics and Biosimilars Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Biologics and Biosimilars Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Biologics and Biosimilars Price (2015-2020) (USD/Unit)
Table 27. Biologics and Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Biologics and Biosimilars Product Type
Table 29. Date of International Manufacturers Enter into Biologics and Biosimilars Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 32. Global Biologics and Biosimilars Sales Share by Type (2015-2020)
Table 33. Global Biologics and Biosimilars Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Biologics and Biosimilars Revenue Share by Type (2015-2020)
Table 35. Biologics and Biosimilars Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 36. Global Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 37. Global Biologics and Biosimilars Sales Share by Application (2015-2020)
Table 38. North America Biologics and Biosimilars Sales by Country (2015-2020) (K Units)
Table 39. North America Biologics and Biosimilars Sales Market Share by Country (2015-2020)
Table 40. North America Biologics and Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Biologics and Biosimilars Revenue Market Share by Country (2015-2020)
Table 42. North America Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 43. North America Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 44. North America Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 45. North America Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 46. Europe Biologics and Biosimilars Sales by Country (2015-2020) (K Units)
Table 47. Europe Biologics and Biosimilars Sales Market Share by Country (2015-2020)
Table 48. Europe Biologics and Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Biologics and Biosimilars Revenue Market Share by Country (2015-2020)
Table 50. Europe Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 51. Europe Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 52. Europe Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 53. Europe Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Biologics and Biosimilars Sales by Region (2015-2020) (K Units)
Table 55. Asia Pacific Biologics and Biosimilars Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Biologics and Biosimilars Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Biologics and Biosimilars Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 59. Asia Pacific Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 61. Asia Pacific Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 62. Latin America Biologics and Biosimilars Sales by Country (2015-2020) (K Units)
Table 63. Latin America Biologics and Biosimilars Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Biologics and Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Biologics and Biosimilars Revenue Market Share by Country (2015-2020)
Table 66. Latin America Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 67. Latin America Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 68. Latin America Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 69. Latin America Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Biologics and Biosimilars Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Biologics and Biosimilars Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Biologics and Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Biologics and Biosimilars Sales by Type (2015-2020) (K Units)
Table 75. Middle East and Africa Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Biologics and Biosimilars Sales by Application (2015-2020) (K Units)
Table 77. Middle East and Africa Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 78. Roche Corporation Information
Table 79. Roche Description and Major Businesses
Table 80. Roche Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Roche Product
Table 82. Roche Recent Development
Table 83. Amgen Corporation Information
Table 84. Amgen Description and Major Businesses
Table 85. Amgen Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Amgen Product
Table 87. Amgen Recent Development
Table 88. AbbVie Corporation Information
Table 89. AbbVie Description and Major Businesses
Table 90. AbbVie Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. AbbVie Product
Table 92. AbbVie Recent Development
Table 93. Sanofi-Aventis Corporation Information
Table 94. Sanofi-Aventis Description and Major Businesses
Table 95. Sanofi-Aventis Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Sanofi-Aventis Product
Table 97. Sanofi-Aventis Recent Development
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Major Businesses
Table 100. Johnson & Johnson Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Recent Development
Table 103. Pfizer Corporation Information
Table 104. Pfizer Description and Major Businesses
Table 105. Pfizer Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Pfizer Product
Table 107. Pfizer Recent Development
Table 108. Novo Nordisk Corporation Information
Table 109. Novo Nordisk Description and Major Businesses
Table 110. Novo Nordisk Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Novo Nordisk Product
Table 112. Novo Nordisk Recent Development
Table 113. Eli Lilly Corporation Information
Table 114. Eli Lilly Description and Major Businesses
Table 115. Eli Lilly Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Eli Lilly Product
Table 117. Eli Lilly Recent Development
Table 118. Novartis Corporation Information
Table 119. Novartis Description and Major Businesses
Table 120. Novartis Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Novartis Product
Table 122. Novartis Recent Development
Table 123. Merck Corporation Information
Table 124. Merck Description and Major Businesses
Table 125. Merck Biologics and Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Merck Product
Table 127. Merck Recent Development
Table 128. 3sbio Corporation Information
Table 129. 3sbio Description and Major Businesses
Table 130. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. 3sbio Product
Table 132. 3sbio Recent Development
Table 133. Changchun High Tech Corporation Information
Table 134. Changchun High Tech Description and Major Businesses
Table 135. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Changchun High Tech Product
Table 137. Changchun High Tech Recent Development
Table 138. CP Guojian Corporation Information
Table 139. CP Guojian Description and Major Businesses
Table 140. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. CP Guojian Product
Table 142. CP Guojian Recent Development
Table 143. Biotech Corporation Information
Table 144. Biotech Description and Major Businesses
Table 145. Biotech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Biotech Product
Table 147. Biotech Recent Development
Table 148. Gelgen Corporation Information
Table 149. Gelgen Description and Major Businesses
Table 150. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 151. Gelgen Product
Table 152. Gelgen Recent Development
Table 153. Innovent Corporation Information
Table 154. Innovent Description and Major Businesses
Table 155. Innovent Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 156. Innovent Product
Table 157. Innovent Recent Development
Table 158. Dong Bao Corporation Information
Table 159. Dong Bao Description and Major Businesses
Table 160. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 161. Dong Bao Product
Table 162. Dong Bao Recent Development
Table 163. Ganlee Corporation Information
Table 164. Ganlee Description and Major Businesses
Table 165. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 166. Ganlee Product
Table 167. Ganlee Recent Development
Table 168. Global Biologics and Biosimilars Sales Forecast by Regions (2021-2026) (K Units)
Table 169. Global Biologics and Biosimilars Sales Market Share Forecast by Regions (2021-2026)
Table 170. Global Biologics and Biosimilars Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 171. Global Biologics and Biosimilars Revenue Market Share Forecast by Regions (2021-2026)
Table 172. North America: Biologics and Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 173. North America: Biologics and Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Europe: Biologics and Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 175. Europe: Biologics and Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Asia Pacific: Biologics and Biosimilars Sales Forecast by Region (2021-2026) (K Units)
Table 177. Asia Pacific: Biologics and Biosimilars Revenue Forecast by Region (2021-2026) (US$ Million)
Table 178. Latin America: Biologics and Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 179. Latin America: Biologics and Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 180. Middle East and Africa: Biologics and Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 181. Middle East and Africa: Biologics and Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 182. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 183. Key Challenges
Table 184. Market Risks
Table 185. Main Points Interviewed from Key Biologics and Biosimilars Players
Table 186. Biologics and Biosimilars Customers List
Table 187. Biologics and Biosimilars Distributors List
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of FiguresFigure 1. Biologics and Biosimilars Product Picture
Figure 2. Global Biologics and Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Interferon Product Picture
Figure 5. Erythropoietin Product Picture
Figure 6. Insulin Product Picture
Figure 7. Vaccines Product Picture
Figure 8. Other Product Picture
Figure 9. Global Biologics and Biosimilars Sales Market Share by Application in 2020 & 2026
Figure 10. Tumor
Figure 11. Diabetes
Figure 12. Cardiovascular
Figure 13. Hemophilia
Figure 14. Other
Figure 15. Biologics and Biosimilars Report Years Considered
Figure 16. Global Biologics and Biosimilars Market Size 2015-2026 (US$ Million)
Figure 17. Global Biologics and Biosimilars Sales 2015-2026 (K Units)
Figure 18. Global Biologics and Biosimilars Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Biologics and Biosimilars Sales Market Share by Region (2015-2020)
Figure 20. Global Biologics and Biosimilars Sales Market Share by Region in 2019
Figure 21. Global Biologics and Biosimilars Revenue Market Share by Region (2015-2020)
Figure 22. Global Biologics and Biosimilars Revenue Market Share by Region in 2019
Figure 23. Global Biologics and Biosimilars Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2019
Figure 25. Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Figure 27. Global Biologics and Biosimilars Sales Market Share by Type in 2019
Figure 28. Global Biologics and Biosimilars Revenue Market Share by Type (2015-2020)
Figure 29. Global Biologics and Biosimilars Revenue Market Share by Type in 2019
Figure 30. Global Biologics and Biosimilars Market Share by Price Range (2015-2020)
Figure 31. Global Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Figure 32. Global Biologics and Biosimilars Sales Market Share by Application in 2019
Figure 33. Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020)
Figure 34. Global Biologics and Biosimilars Revenue Market Share by Application in 2019
Figure 35. North America Biologics and Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 36. North America Biologics and Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Biologics and Biosimilars Sales Market Share by Country in 2019
Figure 38. North America Biologics and Biosimilars Revenue Market Share by Country in 2019
Figure 39. U.S. Biologics and Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 40. U.S. Biologics and Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Biologics and Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 42. Canada Biologics and Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Biologics and Biosimilars Market Share by Type in 2019
Figure 44. North America Biologics and Biosimilars Market Share by Application in 2019
Figure 45. Europe Biologics and Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Biologics and Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Biologics and Biosimilars Sales Market Share by Country in 2019
Figure 48. Europe Biologics and Biosimilars Revenue Market Share by Country in 2019
Figure 49. Germany Biologics and Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Biologics and Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Biologics and Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Biologics and Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Biologics and Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Biologics and Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Biologics and Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Biologics and Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Biologics and Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Biologics and Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Biologics and Biosimilars Market Share by Type in 2019
Figure 60. Europe Biologics and Biosimila